<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02154685</url>
  </required_header>
  <id_info>
    <org_study_id>25623</org_study_id>
    <nct_id>NCT02154685</nct_id>
  </id_info>
  <brief_title>Extinction Updating in Reconsolidation</brief_title>
  <official_title>Reducing Smoking Cue Reactivity and Behavior Via Retrieval-Extinction Mechanism</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of South Carolina</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical University of South Carolina</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Smoking occurs in approximately 21% of the US population, is responsible for an annual&#xD;
      mortality rate of approximately 438,000 citizens, and has an associated healthcare economic&#xD;
      burden of $167 billion. Although pharmacotherapies have improved cessation outcome, the vast&#xD;
      majority of individuals making quit attempts relapse within 5-10 days of cessation. The&#xD;
      hypotheses to be examined in this study may have potentially important implications for&#xD;
      smoking cessation treatment and will, therefore, target the single greatest addiction-related&#xD;
      cause of morbidity and mortality.This study will investigate a novel behavioral strategy for&#xD;
      altering important memory processes that underlie human smoking-related nicotine addiction.&#xD;
      This strategy used in this study employs established cue exposure procedures to putatively&#xD;
      update smoking-related memory with information that will suppress responding to smoking cues.&#xD;
      The goal here is to alter existing nicotine-related memory directly rather than rely&#xD;
      exclusively on the establishment of an inhibitory extinction process, via traditional cue&#xD;
      exposure therapy, which is known to be vulnerable to spontaneous recovery, renewal and&#xD;
      reinstatement. Positive findings would represent a significant advance in exposure-based&#xD;
      therapy for addiction and could lead to a treatment that uniquely targets the problem of&#xD;
      cue-elicited craving and reactivity, thereby addressing a major obstacle to successful&#xD;
      smoking cessation.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      We propose to examine the effects of two sessions of retrieval-extinction (R-E) training in&#xD;
      smokers who are making a quit attempt. Retrieval will be initiated by a brief (5-min.) video&#xD;
      with smoking-related content and the extinction will consist of protracted (1 hr.) exposure&#xD;
      to smoking cues. A control group receiving the same treatment except that the retrieval video&#xD;
      will have nonsmoking/neutral content will serve to demonstrate that retrieval is a key&#xD;
      feature of R-E training. Effects of training on smoking craving and cue reactivity will be&#xD;
      assessed 1-day, 2-weeks and 4-weeks post-training, whereas training effects on indices of&#xD;
      smoking behavior/cessation will be preliminarily assessed 2-weeks and 4-weeks post-training.&#xD;
      It is expected that the R-E training will result in significant and enduring reductions in&#xD;
      craving and reactivity to both novel and familiar smoking cues and have a favorable impact on&#xD;
      smoking. Positive findings from this study could lead to a safe and effective behavioral&#xD;
      intervention that will help smokers overcome the threat to cessation posed by cue-elicited&#xD;
      craving and reactivity, and thereby reduce the burden levied against society by this most&#xD;
      costly addiction. Additionally, this intervention could be modified to treat addiction to&#xD;
      other substances.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>December 2013</start_date>
  <completion_date type="Actual">September 2015</completion_date>
  <primary_completion_date type="Actual">September 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Mean of the Difference in Nicotine Craving between Visits 1 and 2</measure>
    <time_frame>Multiple times points during Visits 1, 2 and 3 (the two retreival sessions and the first test session) as well as the 2-week and 4-week follow-up laboratory test sessions.</time_frame>
    <description>A craving questionnaire and mood form is given to participants to complete at several time points throughout the visit to access nicotine craving.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Nicotine Use at 2-Week Follow-Up</measure>
    <time_frame>A diary is given to participants to record their smoking behaviors everyday for two weeks.</time_frame>
    <description>At the end of the first (24-hr.) and second (2-wk) test session, participants will receive a smoking diary in which to record the occurrence of (a) daily smoking behavior, and (b) daily craving rating over the ensuing 2-week follow-up period.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Nicotine Use at 4-Week Follow-up</measure>
    <time_frame>A diary is given to participants to record their smoking behaviors everyday for two weeks.</time_frame>
    <description>At the end of the first (24-hr.) and second (2-wk) test session, participants will receive a smoking diary in which to record the occurrence of (a) daily smoking behavior, and (b) daily craving rating over the ensuing 2-week follow-up period.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">77</enrollment>
  <condition>Nicotine Addiction</condition>
  <condition>Smoking Cessation</condition>
  <arm_group>
    <arm_group_label>Retrieval-Extinction: Smoking Cues</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>A relatively brief exposure to cues prior to conducting more protracted cue exposure. This is referred to as retrieval-extinction training.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Non-Retrieval Extinction: Neutral Cues</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>This is the group that will not receive retrieval-extinction training and will be exposed to neutral cues.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Retrieval-Extinction</intervention_name>
    <description>A relatively brief exposure to cues prior to conducting more protracted cue exposure. This is referred to as retrieval-extinction training.</description>
    <arm_group_label>Retrieval-Extinction: Smoking Cues</arm_group_label>
    <other_name>R-E</other_name>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Non-Retrieval Extinction</intervention_name>
    <description>Neutral cue exposure.</description>
    <arm_group_label>Non-Retrieval Extinction: Neutral Cues</arm_group_label>
    <other_name>NR-E</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Participants must be able to provide informed consent and function at an intellectual&#xD;
             level sufficient to allow accurate completion of all assessment instruments.&#xD;
&#xD;
          -  Participants must meet DSM-IV criteria for current nicotine dependence and be a daily&#xD;
             cigarette smoker of 10+ cigarettes/day for a minimum duration of three years.&#xD;
&#xD;
          -  Participants must live within a 50-mile radius of the research facility and have&#xD;
             reliable transportation.&#xD;
&#xD;
          -  Participants must be willing to make a quit attempt beginning the night before the&#xD;
             three consecutive daily laboratory sessions (i.e., two retrieval-extinction training&#xD;
             sessions and the test session performed 24-hours after the second retrieval-extinction&#xD;
             training session).&#xD;
&#xD;
          -  Participants must be willing to (a) be overnight smoking abstinent (CO verified) prior&#xD;
             to the baseline smoking cue reactivity assessment, and (b) make a cessation attempt&#xD;
             and be smoking abstinent (CO verified) over the three day period that corresponds to&#xD;
             the two retrieval-extinction training sessions and the test session performed 24-hours&#xD;
             after the second retrieval-extinction training session.&#xD;
&#xD;
          -  Participants must be willing to submit to a breathalyzer (alcohol) assessment and&#xD;
             urine drug screen (for benzodiazepines, methamphetamine, cocaine, marijuana and&#xD;
             opiates) and produce a negative test result on (a) the day of the baseline smoking cue&#xD;
             reactivity assessment, and (b) each of the three consecutive days that correspond to&#xD;
             the two retrieval-extinction training sessions and the test session performed 24-hours&#xD;
             after the second retrieval-extinction training session.&#xD;
&#xD;
          -  Participants must consent to random assignment to the R-E vs. NR-E conditions.&#xD;
&#xD;
          -  Participants must not use smokeless tobacco.&#xD;
&#xD;
          -  Participants must be willing to forego any other medication or behavioral treatment&#xD;
             for smoking cessation during their enrollment in this study (with the exception of a&#xD;
             referral, upon request, to the SC Quitline). Treatment referral will be provided at&#xD;
             the end of the study.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Participants with current/active (untreated) psychotic disorder, current major&#xD;
             depressive disorder (severe), bipolar affective disorder or a severe anxiety disorder&#xD;
             as these conditions would likely interfere with their ability to fulfill the&#xD;
             requirements for successful participation (e.g., provide accurate interview data,&#xD;
             complete study assessments, attend scheduled laboratory visits, etc.).&#xD;
&#xD;
          -  Participants meeting DSM-IV criteria for substance dependence (other than nicotine)&#xD;
             within the past 60 days.&#xD;
&#xD;
          -  Participants who are unwilling or unable to maintain abstinence from alcohol and other&#xD;
             drugs of abuse (benzodiazepines, methamphetamine, cocaine, marijuana and opiates) in&#xD;
             order to comply with Inclusion Criterion f above.&#xD;
&#xD;
          -  Participants currently taking ÃŸ-blockers, anti-arrhythmic agents, psychostimulants or&#xD;
             any other agents known to interfere with heart rate, skin conductance or blood&#xD;
             pressure responses.&#xD;
&#xD;
          -  Current use of any pharmacotherapy or psychotherapy for smoking cessation.&#xD;
&#xD;
          -  Pregnant women (because pregnancy can influence responding during study procedures).&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael Saladin, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medical University of South Carolina</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Medical University of South Carolina</name>
      <address>
        <city>Charleston</city>
        <state>South Carolina</state>
        <zip>29425</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2015</verification_date>
  <study_first_submitted>March 28, 2014</study_first_submitted>
  <study_first_submitted_qc>May 30, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 3, 2014</study_first_posted>
  <last_update_submitted>October 1, 2015</last_update_submitted>
  <last_update_submitted_qc>October 1, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 2, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Smoking</keyword>
  <keyword>Nicotine</keyword>
  <keyword>Addiction</keyword>
  <keyword>Cessation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tobacco Use Disorder</mesh_term>
    <mesh_term>Behavior, Addictive</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

